secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001193125-23-004705
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FLAG SPAC to acquire Calidi Biotherapeutics in $250M business combination
-------------------------------------------------------------------------

- Equity value of Calidi set at $250M; consideration includes FLAG common stock and escalation shares tied to $12/$14/$16/$18 targets.
- Up to 18M additional shares (4.5M per price target) issuable as escalation consideration to pre-merger Calidi stockholders.
- Non-redeeming FLAG public stockholders eligible for up to 2M continuation shares pro rata upon price target achievement.
- Closing requires minimum $15M cash; FLAG may raise up to $40M in PIPE investment and Calidi up to $40M in equity issuances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000119312523004705/0001193125-23-004705-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000119312523004705/d425996d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-004705

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer